Eribulin Mesylate Injection
Product Images NDC 68083-592

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 68083-592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eribulin-spl-carton-label (Eribulin Spl Carton Label)

This is a carton label for Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) for intravenous use, manufactured by Gland Pharma Limited. It contains a single-dose vial with 1 mg of eribulin mesylate in 2 mL solution. The label includes storage instructions and cautions cytotoxicity, specifying single-dose vial discard after use. The package features barcode and regulatory information.*

FDA Label Image

Eribulin-spl-fig-1 (Eribulin Spl Fig 1)

A survival curve chart comparing eribulin mesylate injection to a control group over time in months. The y-axis represents the proportion of patients surviving, and the x-axis represents time up to approximately 36 months. Two lines display survival trends for eribulin mesylate and the control, with patient numbers at risk listed below the x-axis.*

FDA Label Image

Eribulin-spl-fig-2 (Eribulin Spl Fig 2)

A Kaplan-Meier survival curve comparing survival probability over time in months for patients treated with Eribulin Mesylate versus Dacarbazine. The chart includes survival probability on the vertical axis, survival time on the horizontal axis, and a table showing subjects at risk over time for each treatment.*

FDA Label Image

Eribulin-spl-structure (Eribulin Spl Structure)

Chemical structure diagram of eribulin mesylate showing its detailed molecular bonds and arrangement, including the mesylate component.*

FDA Label Image

Eribulin-spl-vial-label (Eribulin Spl Vial Label)

The label for eribulin mesylate injection, 1 mg/2 mL (0.5 mg/mL), indicates it is a sterile solution for intravenous use in a single dose vial, with unused portions to be discarded. The label includes storage instructions to keep at 25°C with permitted excursions and cautions that it is a cytotoxic agent. Manufactured by Gland Pharma Limited, India, the label also displays the product NDC 68083-592-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.